New Guidelines Tackle Antithrombotic Concerns in GI Procedures

The common clinical concerns as to when to continue, hold, and resume antithrombotic agents during acute GI bleeds and elective endoscopy have been allayed by new evidence-based guidelines.

Related Keywords

Norfolk ,Virginia ,United States ,Arizona ,Ohio ,Canada ,America ,American ,Canadian ,Davida Johnson ,Neenas Abraham ,John Vargo ,Eastern Virginia School Of Medicine ,American College Of Gastroenterology ,Division Of Gastroenterology ,Canadian Association Of Gastroenterology ,American College ,Canadian Association ,Mayo Clinic ,Medscape Medical ,American Journal ,Pragmatic Guidelines ,Vexing Area ,Cleveland Clinic ,Eastern Virginia School ,Underline Series ,North America ,Gastrointestinal Hemorrhage ,Gastrointestinal Bleeding ,Leeding Gastrointestinal ,Clinical Guidelines ,Guidelines ,Endoscopy ,Inflammatory Bowel Disease ,Nflammatory Bowel Disease Ibd ,Bd ,Anticoagulation Therapy ,Anticoagulant ,Anticoagulation ,Liver Disease ,Antiplatelet Agent ,Endoscopic Surgery ,Antithrombotics ,Anti Thrombotics ,Antithrombotic Therapy ,Antithrombotic Agents ,Aspirin ,Thromboembo ,